News
-
Open position / Avoin työpaikka: Clinical Study Manager
18.5.2021
We are looking for a Clinical Study Manager to join our team.
Etsimme joukkoomme Clinical Study Manageria.
-
Open position: Marketing Director
10.5.2021
We are looking for a Marketing Director to join our team. Apply by 30.05.2021
-
Open position: QA/RA Director / Avoin työpaikka: Laatu- ja regulaatiojohtaja
31.3.2021
We are looking for a QA/RA Director. Position requires fluent Finnish.
Toimintamme voimakkaasti kasvaessa etsimme joukkoomme laatu- ja regulaatiojohtajaa.
Työpaikkailmoitus -
New assay for rapid detection of SARS-CoV-2 variant strains now available for research use!
22.3.2021
Abacus Diagnostica has developed a SARS-CoV-2 Variants of Concern (VoC) Assay for the GenomEra® CDX platform. In addition to detecting all SARS-CoV-2 strains, the new test detects clinically significant deletions present in the variants first identified in the UK (B.1.1.7), South Africa (B.1.351), and Brazil (P.1). The test is now available as a Research Use Only -product.
-
GenomEra® multiplex assay is now CE marked and available!
18.12.2020
For inquiries, please contact info@abacusdiagnostica.com
-
Two open positions: Application / Service Engineer and Customer Support Scientist
26.10.2020
We are hiring. Apply by 8th of November 2020.
-
Influenza or COVID-19? Reliable diagnosis in 75 minutes with new multiplex assay
23.9.2020
-
GenomEra SARS-CoV-2 Assay Kit is now CE IVD approved and development for four-in-one test (FluA, FluB, RSV, SARS-CoV-2) is on-going
17.7.2020
GenomEra SARS-CoV-2 Assay Kit is now CE IVD approved and available. Please contact your local distributor or us for more information.
In addition, we are developing a four-in-one test for detecting influenza A, influenza B, RSV and SARS-CoV-2. Targeted release is before winter Flu season 2020-2021. -
Investment round is now open
5.6.2020
We warmly welcome all new investors!
#Crowdfunding #CapitalAtRiskhttps://abacusdiagnostica.com/invest
-
Special approval granted for SARS-CoV-2 test
4.5.2020
Finnish regulatory authority Fimea has granted special approval for Abacus to supply the GenomEra RUO SARS-CoV-2 test to Finnish markets.
Press release in Finnish